Nownews生活新聞: 治療曙光！基因檢測選標靶藥 末期腸癌存活增加3.7個月

Changes are afoot at Blogtrottr! By popular request, we're bringing in paid plans with some cool new features (and more on the way). You can read all about it in our blog post.

Nownews生活新聞 www.nownews.com

治療曙光！基因檢測選標靶藥　末期腸癌存活增加3.7個月 Jul 9th 2013, 05:13 〔記者陳鈞凱╱台北報導〕國內劇場泰斗、屏風表演班藝術總監李國修日前因大腸癌病逝，再度引發國人對這國內最多民眾罹患癌症的關注。國內與李國修相同，大腸癌末期轉移病人不少，台灣腸癌病友協會理事長王輝明今（9）天表示，國外新近研究發現，配合KRAS基因檢測，選對標靶藥物，治療更有效，末期大腸癌患者可增加3.7個月存活期。

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions